Medindia
Medindia LOGIN REGISTER
Advertisement

Developments in the Medical Cannabis Market

Thursday, April 6, 2017 Drug News
Advertisement
NEW YORK, April 6, 2017 /PRNewswire/ --
Advertisement

FinancialBuzz.com News Commentary 

Increasing demand for medical cannabis continues to boost the cannabidiol (CBD) market. CBD is one of the active cannabinoids in the cannabis plant and is considered to have significant medical benefits. According to a report published by The Hemp Business Journal, the U.S. CBD market was worth $202 million in 2015 and is expected to reach $2.1 billion by 2020. The report estimated that $450 million of the projected sales will be from hemp based sources and the rest from marijuana sources. The expanding market is also driven by growing acceptance of cannabis. 28 U.S. states have legalized cannabis for medical use. Naturally Splendid Enterprises Ltd. (OTC: NSPDF) (TSX-V: NSP), MCig Inc. (OTC: MCIG), American Cannabis Company, Inc. (OTC: AMMJ), Mountain High Acquisitions Corp. (OTC: MYHI), Surna Inc. (OTC: SRNA)
Advertisement

Matt Karnes from Greenwave Advisors stated, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only - this is in addition to the 28 states plus DC that have legalized medical marijuana." A report by Forbes points out there is evidence that traditional cannabis users are willing to give CBD a try. Outco, the largest licensed cultivator in Southern California published data that shows 38% of users and non-users claimed they wanted to learn more about CBD oil.

Naturally Splendid Enterprises Ltd. (OTCQB: NSPDF) (TSX-V: NSP) announced earlier today, "It has signed a definitive agreement with Canature Processing Ltd., ('Canature'), an industry leader in the freeze dried pet foods and treats market for the inclusion of Naturally Splendid's proprietary HempOmega™ into a range of products. Naturally Splendid and Canature have entered into a definitive agreement, whereas Canature will begin work to formulate Naturally Splendid's proprietary HempOmega™ into Canature's existing product lines and begin R&D on future pet food and treat products. Canature will incorporate HempOmega™ into Canature's house brands and potentially, into private label client products as well. Naturally Splendid will grant Canature exclusive rights for the application of HempOmega™ into freeze-dried pet food and treats for an initial term of two (2) years in defined categories and territories."

Naturally Splendid CEO Mr. Dave Eto states, "The pet treat/food industry is growing and expanding. Our agreement with Canature, one of Canada's largest pet food manufacturers, is indicative of the opportunities we are developing to promote the use of HempOmega™ as an ingredient in the pet food/treat industry. This is a key strategic alliance and opportunity to enter the growing premium pet food sector with an organization that values high quality and innovative products. Hemp Omega is proving to be an excellent fortification ingredient for not only humans but for those we consider our 'best friends' and we are very excited with the possibilities to enhance the health and nutrition of the entire family. As such, we will continue to explore HempOmega™ opportunities in multiple categories outside of the pet food/treat industry such as dairy, baking, beverages and cosmetics."

MCig Inc. (OTCQB: MCIG) is engaged in manufacturing, marketing and distributing electronic cigarettes, vaporizers and accessories under the mCig brand name. The Company offers electronic cigarettes and related products through its online store, mcig.org, as well as through its wholesale, distributor and retail programs. Its segments include construction, Internet sales and wholesale. The Construction segment develops, designs, engineers, and constructs modular buildings with elements that assist cannabis growers in the market. Each modular building is designed for each customer. The Company tracks various retail sales, through the Internet segment through the consolidation of all online retail sales from various websites. It provides streamlining of administrative and documentation services, consolidation of inventories and supports economy of scale. The wholesale segment works with distribution channels in electronic vaporizing cigarettes and marijuana cigarettes, among others.

American Cannabis Company, Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. The company utilizes its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. On March 23rd, 2017 the company announced it has secured its first client in the Canadian province of Alberta. The company will help the client plan business operations and develop a financial model to pave the way for license acquisition. American Cannabis Company will provide the Client with cultivation and manufacturing facility conceptual design work to further advance the project build. The company expects to utilize this contract to secure additional revenues through long-term consulting agreements and potential sales of ancillary products.

Mountain High Acquisitions Corp. (OTCQB: MYHI) is a diversified holding company focused on the acquisition and development of businesses within the hemp and CBD nutraceutical sectors. The Company's wholly owned subsidiary, GreenLife BotaniX, Inc. is a California-based developer and marketer of the 'SuperCBD' brand of CBD hemp oil infused nutraceutical products. GreenLife currently features over a dozen CBD-based products on its e-commerce website, including four primary flagship products; 'Super CBD Drops' - a high-potency vanilla flavored vegan hemp oil tincture, 'Super CBD Lotion' - a CBD lotion made with a unique blend of CBD, eucalyptus oil, and vitamins and minerals, 'Super CBD Lip Balm' - a medicated ointment intended for a variety of skin problems, cuts and rashes, and 'Super CBD Pills' - a concentrated CBD dose in pill form for easy ingestion.

Surna Inc. (OTCQB: SRNA) engineers and manufactures innovative technology and products that address the energy and resource intensive nature of indoor cultivation. The company's current focus lies in supplying industrial solutions to commercial indoor cannabis cultivation facilities. Early in February, the company signed a contract with Vancouver's Sante Veritas Therapeutic to design and provide equipment for the environmental control system in its first commercial cultivation facility. Surna CEO Trent Doucet said, "Cannabis for medical use is legal throughout all of Canada, making the market an outstanding opportunity for continued growth. We now have five clients in Canada, and our sales team continues to see significant activity from both new market entrants as well as existing clients planning expansion."

Please sign up now at http://www.FinancialBuzz.com to receive alerts on trending financial news from all these companies. 'The Latest Buzz in Financial News'

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com has been compensated a total of ten thousand dollars for financial news dissemination and pr services by a third party non affiliate for naturally splendid enterprises ltd. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information: Media Contact: [email protected] +1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close